Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions

Eli Lilly said it would cap the out-of-pocket cost of insulin at $35 per month. More than 8 million people with diabetes rely on insulin, which is notoriously expensive in the U.S.